These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Management of in-transit melanoma metastases: a review. Nan Tie E; Henderson MA; Gyorki DE ANZ J Surg; 2019 Jun; 89(6):647-652. PubMed ID: 30414233 [TBL] [Abstract][Full Text] [Related]
67. [Hyperthermic regional perfusion in malignant melanoma of an extremity]. Andersson AP; Drzewiecki KT Ugeskr Laeger; 1992 Oct; 154(41):2815-9. PubMed ID: 1413222 [TBL] [Abstract][Full Text] [Related]
68. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study. Fraker DL; Alexander HR; Andrich M; Rosenberg SA J Clin Oncol; 1996 Feb; 14(2):479-89. PubMed ID: 8636761 [TBL] [Abstract][Full Text] [Related]
69. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response. Aloia TA; Grubbs E; Onaitis M; Mosca PJ; Cheng TY; Seigler H; Tyler DS Arch Surg; 2005 Nov; 140(11):1115-20. PubMed ID: 16301451 [TBL] [Abstract][Full Text] [Related]
70. Medical Options for the Adjuvant Treatment and Management of Pediatric Melanoma. Raef HS; Friedmann AM; Hawryluk EB Paediatr Drugs; 2019 Apr; 21(2):71-79. PubMed ID: 30924056 [TBL] [Abstract][Full Text] [Related]
71. Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot study. Belli F; Arienti F; Rivoltini L; Santinami M; Mascheroni L; Prada A; Ammatuna M; Marchesi E; Parmiani G; Cascinelli N Melanoma Res; 1992 Nov; 2(4):263-71. PubMed ID: 1490114 [TBL] [Abstract][Full Text] [Related]
72. Hyperthermic isolated regional perfusion of the limb with carboplatin. Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648 [TBL] [Abstract][Full Text] [Related]
74. Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion. Rashid OM; Sloot S; Zager JS Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1355-64. PubMed ID: 25176398 [TBL] [Abstract][Full Text] [Related]
75. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities. Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833 [TBL] [Abstract][Full Text] [Related]
77. The success of TNF alpha in isolated limb perfusion for irresectable extremity soft tissue sarcomas, melanoma and carcinomas: observations in patients and preclinical perfusion models. Eggermont AM Gan To Kagaku Ryoho; 1996 Sep; 23(11):1357-70. PubMed ID: 8854755 [No Abstract] [Full Text] [Related]